Hui Shao

3.0k total citations
186 papers, 1.8k citations indexed

About

Hui Shao is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Hui Shao has authored 186 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Endocrinology, Diabetes and Metabolism, 39 papers in Economics and Econometrics and 31 papers in Epidemiology. Recurrent topics in Hui Shao's work include Diabetes Treatment and Management (54 papers), Diabetes Management and Research (46 papers) and Health Systems, Economic Evaluations, Quality of Life (35 papers). Hui Shao is often cited by papers focused on Diabetes Treatment and Management (54 papers), Diabetes Management and Research (46 papers) and Health Systems, Economic Evaluations, Quality of Life (35 papers). Hui Shao collaborates with scholars based in United States, China and Germany. Hui Shao's co-authors include Lizheng Shi, Vivian Fonseca, Charles Stoecker, Chi-Ying Tsui, Ping Zhang, Shuqian Liu, Yingnan Zhao, Jingchuan Guo, Carlos Irwin A. Oronce and Yichen Zhang and has published in prestigious journals such as JAMA, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Hui Shao

171 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui Shao United States	23	698	221	207	199	184	186	1.8k
Xueying Qin China	17	713 1.0×	259 1.2×	439 2.1×	40 0.2×	405 2.2×	79	2.3k
Shigeo Tomura Japan	26	156 0.2×	234 1.1×	158 0.8×	43 0.2×	182 1.0×	81	1.7k
Kosuke Inoue Japan	30	674 1.0×	432 2.0×	283 1.4×	122 0.6×	561 3.0×	186	3.0k
Joe Ramsdell United States	33	149 0.2×	179 0.8×	244 1.2×	95 0.5×	140 0.8×	85	3.2k
Xiaomin Sun China	26	340 0.5×	124 0.6×	319 1.5×	34 0.2×	473 2.6×	104	2.2k
Kam-Pui Lee Hong Kong	27	102 0.1×	79 0.4×	97 0.5×	45 0.2×	170 0.9×	107	2.9k
Kelly Cho United States	26	419 0.6×	435 2.0×	320 1.5×	252 1.3×	488 2.7×	137	2.9k
Vidar Hjellvik Norway	23	139 0.2×	107 0.5×	99 0.5×	98 0.5×	180 1.0×	106	1.7k
Robert Hopkins United States	15	67 0.1×	81 0.4×	158 0.8×	72 0.4×	91 0.5×	96	1.2k
Kyoung Hwa Ha South Korea	24	640 0.9×	205 0.9×	369 1.8×	36 0.2×	219 1.2×	87	1.7k

Countries citing papers authored by Hui Shao

Since Specialization

Citations

This map shows the geographic impact of Hui Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Shao more than expected).

Fields of papers citing papers by Hui Shao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Shao. The network helps show where Hui Shao may publish in the future.

Co-authorship network of co-authors of Hui Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Shao. A scholar is included among the top collaborators of Hui Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Shao. Hui Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jaffee, Michael S., et al.. (2025). Glycemic control, medications, and onset of Alzheimer’s disease and related dementias: A scoping review on diabetes management in people with mild cognitive impairment. 1(1). 100008–100008.

Tang, Ting, Charles Stoecker, Alessandra N. Bazzano, et al.. (2024). CO40 Zero Dollar Drug Co-Pay Program Increases Medication Adherence and Utilization Among Members With Diabetes in Louisiana. Value in Health. 27(6). S23–S24.

Ma, Wenjing, et al.. (2024). Uncertainty-Aware Pre-Trained Foundation Models for Patient Risk Prediction via Gaussian Process. PubMed. 2024(Companion). 1162–1165. 1 indexed citations

Kulshreshtha, Ambar, K.M. Venkat Narayan, Mohammed K. Ali, et al.. (2024). Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial. Diabetes Obesity and Metabolism. 26(9). 3958–3968. 2 indexed citations

Guo, Jingchuan, Huilin Tang, Hui Shao, et al.. (2024). Sodium‐glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real‐world patients with type 2 diabetes. Diabetes Obesity and Metabolism. 26(12). 5727–5736. 4 indexed citations

Allen, John M., Hui Shao, William T. Donahoo, et al.. (2024). Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes. PLoS ONE. 19(1). e0297208–e0297208. 10 indexed citations

Guan, Dawei, et al.. (2024). Trends in utilization patterns of newer glucose-lowering drugs in US adults with type 2 diabetes and a history of coronary heart disease or heart failure: 2005–2019. Primary care diabetes. 18(5). 561–563. 1 indexed citations

Zhang, Yongkang, et al.. (2023). Healthcare Utilization and Mortality After Hospice Live Discharge Among Medicare Patients With and Without Alzheimer’s Disease and Related Dementias. Journal of General Internal Medicine. 38(10). 2272–2278. 7 indexed citations

Tang, Huilin, et al.. (2023). Cost Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors Compared with Mineralocorticoid Receptor Antagonists among Patients with Heart Failure and a Reduced Ejection Fraction. SHILAP Revista de lepidopterología. 8(1). 1 indexed citations

10.

Shao, Hui, et al.. (2023). A prediction model on incident chronic kidney disease among individuals with type 2 diabetes in the United States. Diabetes Obesity and Metabolism. 25(10). 2862–2868. 5 indexed citations

11.

Lyu, Tianchen, William T. Donahoo, Yonghui Wu, et al.. (2023). The role of health system penetration rate in estimating the prevalence of type 1 diabetes in children and adolescents using electronic health records. Journal of the American Medical Informatics Association. 31(1). 165–173. 1 indexed citations

12.

Tang, Shichao, Hui Shao, Mohammed K. Ali, & Ping Zhang. (2023). Recommended and Prevalent Use of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter-2 Inhibitors in a National Population-Based Sample. Annals of Internal Medicine. 176(4). 582–583. 11 indexed citations

13.

Zhang, Yichen, Ping Zhang, Shichao Tang, et al.. (2023). Incremental burden on health‐related quality of life, health service utilization and direct medical expenditures associated with cognitive impairment among non‐institutionalized people with diabetes aged 65 years and older. Diabetes Obesity and Metabolism. 26(1). 275–282. 3 indexed citations

14.

Shi, Lizheng, Vivian Fonseca, Neda Laiteerapong, et al.. (2023). 5‐Year simulation of diabetes‐related complications in people treated with tirzepatide or semaglutide versus insulin glargine. Diabetes Obesity and Metabolism. 26(2). 463–472. 5 indexed citations

15.

Shao, Hui, et al.. (2022). Predicting incident heart failure among patients with type 2 diabetes mellitus: The DM‐CURE risk score. Diabetes Obesity and Metabolism. 24(11). 2203–2211. 10 indexed citations

16.

Shao, Hui, et al.. (2021). Trends in Total and Out-of-pocket Payments for Noninsulin Glucose-Lowering Drugs Among U.S. Adults With Large-Employer Private Health Insurance From 2005 to 2018. Diabetes Care. 44(4). 925–934. 10 indexed citations

17.

Shao, Hui, Lizheng Shi, & Vivian Fonseca. (2020). Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium–Glucose Transporter 2 Inhibitors. Diabetes Care. 43(7). 1530–1536. 17 indexed citations

18.

Shao, Hui, Vivian Fonseca, Roy Furman, Luigi Meneghini, & Lizheng Shi. (2020). Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications: A Simulation Study. Diabetes Care. 43(11). 2847–2852. 10 indexed citations

19.

Shao, Hui, Ji Lin, Xiaohui Zhuo, et al.. (2019). Influence of Diabetes Complications on HbA1c Treatment Goals Among Older U.S. Adults: A Cost-effectiveness Analysis. Diabetes Care. 42(11). 2136–2142. 8 indexed citations

20.

Shi, Qian, Peter Lee, Hui Shao, et al.. (2017). Evaluation of the Quality Blue Primary Care program on health outcomes.. PubMed. 23(12). e402–e408. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact